Daniel L. Sambursky
Direttore/Membro del Consiglio presso Rapid Pathogen Screening, Inc.
Posizioni attive di Daniel L. Sambursky
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Rapid Pathogen Screening, Inc.
 Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Daniel L. Sambursky
Statistiche
Distribuzione geografica
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 1 |
Settori
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Rapid Pathogen Screening, Inc.
Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL. | Health Services |
- Borsa valori
- Insiders
- Daniel L. Sambursky
- Esperienza
